Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
ACTOVEGIN, Adaptate, AHA, AIPHAGAN, Alagille, Alembic, Alnylam, AML, analyzed, anemia, antiviral, Apr, ARALAST, aspire, atresia, AttenukineTM, Aug, AVISA, awaiting, barrier, Beam, biliary, bio, biodegradable, biographical, BlackRock, blended, Bocconi, booster, broke, Businesswomen, buyback, campaign, Cargo, CDE, CDTO, CEPROTIN, chairperson, Chancery, charitable, Charter, chemotherapy, cidofovir, Classical, CLP, CMML, CMV, CNDAP, coagulant, Coagulation, comfort, Croda, Cure, Dainippon, Darden, Dartmouth, decade, dexlansoprazole, diagnostic, Distinguished, DNA, Dolby, EE, EFPIA, Elizabeth, enantone, endorsed, endpoint, entail, evolution, Evozyne, Excellence, EXKIVITY, familial, family, feet, fell, Fellow, female, fibrostenotic, figure, firmwide, floor, foscarnet, FOSRENOL, Frazier, fSCIg, Gabriele, ganciclovir, gastroesophageal, genotypic, GERD, GHG, GPD, ground, Harvey, healing, heartburn, Hill, HilleVax, HSCT, hypersomnia, ID, ImmTOR, Immusoft, imperative, inbound, infertility, Inpatient, Intermuscular, intrahepatic, Intramuscular, invasion, ISP, IST, ITAC, iTTP, JCR, job, John, Jun, Kellogg, Kennedy, kg, Kimberly, Kobe, ku, Kymera, landfill, Lehman, leiomyomata, LIVETENCITY, LIVTENCITY, Lupin, LUPRON, Luxna, mantle, Maraganore, maralixibat, MCL, Mesothelin, MIB, Milan, Mirum, mobocertinib, modakafusp, movement, Mudd, myelomonocytic, needle, Northwestern, nuvaxovid, Oak, OBU, occupancy, OCE, OECD, Omicron, onset, operationalized, Oxford, pabinafusp, PANTHER, particulate, PAS, perioperative, pevonedistat, piggyBac, pillar, PIPL, platinum, Polytechnic, ponatinib, Poseida, pp, PreviPharma, progranulin, prompted, PROTHROMPLEX, PSU, puberty, rapid, rebound, redefine, Reed, Regensburg, Ricci, roll, Rome, RSU, Russian, Sandoz, Sanitary, satisfaction, scrutiny, SE, Selecta, shipping, Sigmapharm, signal, smart, societal, Sosei, spearheaded, spikevax, square, star, survival, symptomatic, synthesizing, TAC, tau, tenure, Tor, transferrin, Trieste, TV, unclarity, undelivered, undistributed, Unfit, unpunctured, unremitted, val, valganciclovir, variant, VBU, VECTIBIX, venetoclax, Vergata, Virginia, Waring, weighing, Wellesley, withdrawn, xeno, Yodogawa
Removed:
abandon, acellular, activating, admitted, aerospace, Akzo, Alogliptin, Amato, amyotrophic, artery, Asahi, Assistant, Asthma, attenukine, Automobile, BacTrap, bid, Biodefense, bioterrorism, calcium, Centre, CEPI, Chase, checkpoint, claiming, Coalition, conformed, conjunction, COO, coronary, correlate, count, DAAO, de, deleveraging, depression, discontinuance, Dopamine, DOYUKAI, Dresser, eASC, EBARA, effort, Electron, EM, emphasizing, employer, Epidemic, ethical, existed, explore, feasibility, Fellowship, forma, Francisco, Fred, gained, GAVI, GM, grossed, Guangdong, harbor, headed, hearing, Hemoshear, hifibio, HPT, Huntington, Hutchinson, IAVI, IGF, incidental, INCJ, indemnification, indemnify, indenture, interacting, Interbrew, Inviragen, ITP, Jeffrey, JPMorgan, Kajima, Kawasaki, Keidanren, KEIZAI, Komatsu, labor, LATAM, leased, LigoCyte, longstanding, Louisiana, LPC, lymphocytic, Mallinckrodt, Marek, Markman, Masahiro, mature, Medipal, Melinda, Mersana, micro, Mississippi, Mizuho, Modell, moved, MUFG, Multilab, NEDD, negotiating, NEXON, NIDEC, Nihon, Nobel, Nomura, noncorporate, Novamed, Novimmune, officially, Opex, Organon, originating, outlined, Ovarian, oxidase, pace, pan, pattern, PENTASA, pill, pioglitazone, platelet, player, polio, positioning, PPTA, promising, Protease, provisional, PTH, pulmonary, purport, PvP, Rajeev, ran, reacquired, reacquisition, realignment, Redirected, remained, remove, Rent, repaid, resetting, retrospective, returning, Ricardo, seasoned, Shanghai, shared, side, Sony, SPRInT, sublease, Sunstar, Tabular, takeover, Techpool, tendered, trained, unfiled, user, velaglucerase, Venkayya, Virology, whilst, White, Yakuhin, Yasuhiko
Filing tables
Filing exhibits
Associated TAK transcripts
TAK similar filings
Filing view
External links
Exhibit 15.2
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the registration statements (No. 333-239422 and No. 333-260543) on Form S-8 of our reports dated June 29, 2022, with respect to the consolidated financial statements of Takeda Pharmaceutical Company Limited and the effectiveness of internal control over financial reporting.
/s/KPMG AZSA LLC
Tokyo, Japan
June 29, 2022